Kirlioglu (15) investigated the relationship between inflammatory and metabolic markers and newly diagnosed BD but failed to find evidence supporting high-sensitive C-reactive protein and homocysteine as markers in newly diagnosed BD. This evidence concerns the gene CRP and Behcet disease.